Guided Therapeutics, Inc.
GTHP
$0.25
$0.0525.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -64.15% | 8.28% | -89.46% | 34.51% | 0.31% |
| Total Depreciation and Amortization | 3.70% | 0.00% | 8.00% | 4.17% | 0.00% |
| Total Amortization of Deferred Charges | 1.85% | -20.59% | 1.49% | 76.32% | 72.73% |
| Total Other Non-Cash Items | 128.75% | -41.18% | 2,820.00% | 41.18% | -125.76% |
| Change in Net Operating Assets | 113.39% | -17.95% | 1,850.00% | -94.91% | 298.55% |
| Cash from Operations | -5.05% | -63.91% | 48.94% | 0.30% | 29.81% |
| Capital Expenditure | 100.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -- | -- | -- |
| Total Debt Issued | 98.41% | -82.25% | 73.17% | 2.50% | 6.95% |
| Total Debt Repaid | -57.60% | -76.06% | 51.70% | 29.67% | -151.81% |
| Issuance of Common Stock | 18.08% | -- | -- | -- | 78.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 288.24% | 62.22% | -- | -- | 100.00% |
| Cash from Financing | 47.51% | -24.27% | 312.07% | -88.97% | 34.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 75.51% | -240.00% | 125.64% | -240.72% | 339.51% |